These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 9554441)
1. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. Gallo O; Masini E; Morbidelli L; Franchi A; Fini-Storchi I; Vergari WA; Ziche M J Natl Cancer Inst; 1998 Apr; 90(8):587-96. PubMed ID: 9554441 [TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase. Jadeski LC; Chakraborty C; Lala PK Int J Cancer; 2003 Sep; 106(4):496-504. PubMed ID: 12845643 [TBL] [Abstract][Full Text] [Related]
3. Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma. Franchi A; Massi D; Santucci M; Masini E; Rossi Degl'Innocenti D; Magnelli L; Fanti E; Naldini A; Ardinghi C; Carraro F; Gallo O J Pathol; 2006 Feb; 208(3):439-45. PubMed ID: 16278821 [TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Franchi A; Santucci M; Masini E; Sardi I; Paglierani M; Gallo O Cancer; 2002 Nov; 95(9):1902-10. PubMed ID: 12404284 [TBL] [Abstract][Full Text] [Related]
5. Correlation between nitric oxide and cyclooxygenase-2 pathways in head and neck squamous cell carcinomas. Gallo O; Fabbroni V; Sardi I; Magnelli L; Boddi V; Franchi A Biochem Biophys Res Commun; 2002 Dec; 299(4):517-24. PubMed ID: 12459168 [TBL] [Abstract][Full Text] [Related]
6. Reactivity of tumor-draining lymph nodes and the nitric oxide pathway. Davel L; Eijan AM; Sales ME; Español A; D'Agostino A; Piccardo I; Lauría L; De Lustig ES; Jasnis MA Int J Oncol; 2002 Jan; 20(1):59-67. PubMed ID: 11743643 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. Rosbe KW; Prazma J; Petrusz P; Mims W; Ball SS; Weissler MC Otolaryngol Head Neck Surg; 1995 Nov; 113(5):541-9. PubMed ID: 7478643 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of non-small cell lung cancer cell migration by grape seed proanthocyanidins is mediated through the inhibition of nitric oxide, guanylate cyclase, and ERK1/2. Punathil T; Katiyar SK Mol Carcinog; 2009 Mar; 48(3):232-242. PubMed ID: 18680102 [TBL] [Abstract][Full Text] [Related]
10. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. Siragy HM; Carey RM J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502 [TBL] [Abstract][Full Text] [Related]
11. In vitro effects of nitric oxide synthase inhibitor L-NAME on oral squamous cell carcinoma: a preliminary study. Shang ZJ; Li ZB; Li JR Int J Oral Maxillofac Surg; 2006 Jun; 35(6):539-43. PubMed ID: 16497478 [TBL] [Abstract][Full Text] [Related]
12. Nitric oxide synthase (NOS2/3) expression in head and neck squamous cell carcinomas in correlation with clinical patterns. Mozet C; Marin DG; Bertolini J; Tannapfel A; Wichmann G; Dietz A Onkologie; 2009 Nov; 32(11):655-60. PubMed ID: 19887869 [TBL] [Abstract][Full Text] [Related]
13. Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Jadeski LC; Hum KO; Chakraborty C; Lala PK Int J Cancer; 2000 Apr; 86(1):30-9. PubMed ID: 10728591 [TBL] [Abstract][Full Text] [Related]
14. Chronic treatment with nitric oxide synthase (NOS) inhibitor profoundly reduces cerebellar NOS activity and cyclic guanosine monophosphate but does not modify minimum alveolar anesthetic concentration. Adachi T; Shinomura T; Nakao S; Kurata J; Murakawa M; Shichino T; Seo N; Mori K Anesth Analg; 1995 Oct; 81(4):862-5. PubMed ID: 7574024 [TBL] [Abstract][Full Text] [Related]
15. An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats. Schwartz D; Schwartz IF; Blantz RC J Lab Clin Med; 2001 Feb; 137(2):107-14. PubMed ID: 11174467 [TBL] [Abstract][Full Text] [Related]
16. Effects of aminoguanidine on nitric oxide production induced by inflammatory cytokines and endotoxin in cultured rat hepatocytes. Zhang GL; Wang YH; Teng HL; Lin ZB World J Gastroenterol; 2001 Jun; 7(3):331-4. PubMed ID: 11819785 [TBL] [Abstract][Full Text] [Related]
17. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity. Handy RL; Moore PK Br J Pharmacol; 1998 Mar; 123(6):1119-26. PubMed ID: 9559895 [TBL] [Abstract][Full Text] [Related]
18. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression. Shang ZJ; Li JR J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226 [TBL] [Abstract][Full Text] [Related]
19. Inducible nitric oxide synthase expression and erythropoietin production in human hepatocellular carcinoma cells. Yoshioka K; Thompson J; Miller MJ; Fisher JW Biochem Biophys Res Commun; 1997 Mar; 232(3):702-6. PubMed ID: 9126339 [TBL] [Abstract][Full Text] [Related]
20. Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats. Makuch W; Mika J; Rojewska E; Zychowska M; Przewlocka B Neuropharmacology; 2013 Dec; 75():445-57. PubMed ID: 24035921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]